Home Infusion Therapy Devices Market Research Report - Global Forecast till 2027

Global Home Infusion Therapy Devices Market Research Report: Information by Product (Infusion Pumps, Intravenous Sets, IV Cannulas, Needleless Connectors, Elastomeric Pumps), Application (Anti-Infectives, Endocrinology, Enteral nutrition, Hydration Therapy, Chemotherapy) and Region (Americas, Europe, Asia-Pacific, Middle East & Africa) - Forecast till 2027

ID: MRFR/HC/6434-HCR | February 2021 | Region: Global | 90 pages

Please note that the assessment period of the report has been updated from 2019-2024 to 2020-2027.Cordially fill Sample form for the updated data.

Market Scenario


The global home infusion therapy devices market is expected to grow significantly over the forecast period. The market held a market value of USD 20.1 Billion in 2017 and is projected to register a CAGR of 7.1% over the forecast period. Home infusion therapy devices are devices that are used to deliver medications through a needle or catheter into a vein outside the hospital or clinical setting. The growing demand for home infusion therapy devices is due to factors such as rising geriatric population and raising awareness regarding the services of home infusion.


Additionally, the growing incidence of cancer, diabetes, immune deficiencies, and infections, along with favorable reimbursement scenarios, is driving the growth of the market. For instance, according to the United Nations, the older population is likely to reach 425 million by 2050. This rise in the aging population will lead to a rise in home care as this population is highly prone to various chronic disorders and is at a higher risk of developing complications which are also likely to drive the market.


However, lack of trained manpower along with vast product recalls and lack of standard usage guidelines are the key factors limiting the growth of the market.  


Segmentation


The global home infusion therapy devices market has been segmented into product and application.


By product, the market has been segmented into infusion pumps, intravenous sets, IV cannulas, needleless connectors, elastomeric pumps, and others. The intravenous sets segment is expected to register the highest CAGR during the forecast period due to growing demand.


On the basis of application, the market has been segmented into anti-infectives, endocrinology, enteral nutrition, chemotherapy, hydration therapy, parenteral infusion, and others.


The global home infusion therapy devices market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The home infusion therapy devices market in the Americas has further been segmented into North America and Latin America, with the North American market divided into the US and Canada.


The European home infusion therapy devices market has been segmented into Western Europe and Eastern Europe. The Western Europe home infusion therapy devices market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 


The home infusion therapy devices market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The home infusion therapy devices market in the Middle East & Africa has been segmented into the Middle East and Africa.


Key Players


Braun Melsungen AG, Fresenius Kabi AG, Baxter International Inc., Johnson & Johnson Private Limited, Pfizer Inc., Terumo Corporation, Smith & Nephew, Care Fusion Corporation are some of the prominent players in the global home infusion therapy devices market.


Regional Market Summary


Global Home Infusion Therapy Devices Market Share (%), by Region, 2018  Home Infusion Therapy Devices Market_Image


Source: White Papers, Company Presentations, Annual Reports


The Americas is the market leader and has an attractive market for home infusion therapy devices owing to the increasing prevalence of cardiovascular, neurological, and infections pertaining to the rising geriatric population, which is a major trigger factor. For instance, according to the US Census Bureau, in 2016, around 49.2 million residents were aged 65 and above. This huge older population led to over 15.2% of the total population, which is likely to drive the market.


Additionally, according to the Canadian Cancer Society, in 2017, an estimated 206,200 new cases of cancer and 80,800 deaths occurred in Canada. This huge older population and increasing cases of cancer are driving the home infusion devices market. Furthermore, the Americas is witnessing rampant advancements in technology, and increasing government initiatives, and funding for research in the medical devices sector is driving the market growth.


Europe accounts for the second largest market and holds a healthy share in the global home infusion therapy devices market due to major driving factors like availability of advanced treatment facilities, increasing healthcare expenditure, and flourishing medical device industry due to the presence of major market players. Additionally, the rising prevalence of chronic disorders such as cardiovascular disorders, neurological disorders, among other disorders, is driving the growth of the market. Additionally, rising surgical procedures is driving the growth as home care is required after surgical procedures. According to the National Health Service (NHS), surgery is the most important treatment offered by the NHS in secondary care within the UK. Furthermore, in 2015, NHS estimated that there were around 4.7 million surgical admissions in England, out of which 1.3 million procedures were for general surgery and around 1.2 million procedures were for trauma and orthopedics.


Asia Pacific is expected to be the fastest growing market, owing to the huge patient pool, a faster adaptation of healthcare technology, government initiatives to increase the healthcare quality, and availability of favorable insurance policies. Moreover, due to lower cost of clinical trials, research key players have been setting up their regional headquarters and manufacturing plants in Singapore, China, Japan, Korea, and Australia which make a positive growth curve in home infusion therapy devices market in future.


The Middle East & Africa is expected to show the least growth in the market due to some major factors such as lack of awareness, limited access, and availability of treatment facilities. In the Middle East, the United Arab Emirates and Saudi Arabia is the largest market share owing to the development of the healthcare industry and the rising availability of specialty care centers.


Global Home Infusion Therapy Devices Market, by Product



  • Infusion Pumps

  • Intravenous Sets

  • IV Cannulas

  • Needleless Connectors

  • Elastomeric Pumps

  • Others


Global Home Infusion Therapy Devices Market, by Application



  • Anti-Infectives

  • Endocrinology

  • Enteral nutrition

  • Chemotherapy

  • Hydration Therapy

  • Parenteral Infusion

  • Other


Global Home Infusion Therapy Devices Market, by Region



  • Americas

    • North America

      • US

      • Canada



    • Latin America





  • Europe

    • Western Europe

      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe



    • Eastern Europe





  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific





  • The Middle East & Africa

    • Middle East

    • Africa




Intended Audience



  • Medical device manufacturer

  • Channel partners

  • Industry association

  • Governments and investment communities

  • Research organizations and associations

  • Healthcare industry



Frequently Asked Questions (FAQ) :


The home infusion therapy devices market is projected to grow at a 7.1% CAGR between 2019-2024.

The Americas is predicted to lead the home infusion therapy devices market.

Leading players profiled in the home infusion therapy devices market include Care Fusion Corporation, Smith & Nephew, Terumo Corporation, Pfizer Inc., Johnson & Johnson Private Limited, Baxter International Inc., Fresenius Kabi AG, and Braun Melsungen AG.

Specific strategies adopted by industry players to create a foothold in the home infusion therapy devices market include joint ventures, acquisitions, R&D, and product launches.

Table of Contents

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Detection Technique Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Home Infusion Therapy Devices Market, by Product

6.1 Introduction

6.2 Infusion Pumps

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3 Intravenous Sets

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.4 IV Cannulas

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.5 Needleless Connectors

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.6 Elastomeric Pumps

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.7 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 7. Global Home Infusion Therapy Devices Market, by Application

7.1 Introduction

7.2 Anti-Infectives

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3 Endocrinology

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4 Enteral nutrition

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.5 Chemotherapy

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.5 Hydration Therapy

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.5 Parenteral Infusion

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.5 Other

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 8. Global Home Infusion Therapy Devices Market, by Region

8.1 Introduction

8.2 Americas

8.2.1 North America

10.2.1.1 US

10.2.1.2 Canada

8.2.2 Latin America

8.3 Europe

8.3.1 Western Europe

8.3.1.1 Germany

8.3.1.2 France

8.3.1.3 Italy

8.3.1.4 Spain

8.3.1.5 UK

8.3.1.6 Rest of Western Europe

8.3.2 Eastern Europe

8.4 Asia-Pacific

8.4.1 Japan

8.4.2 China

8.4.3 India

8.4.4 Australia

8.4.5 South Korea

8.4.6 Rest of Asia-Pacific

8.5 Middle East & Africa

8.5.1 Middle East

8.5.2 Africa

Chapter 9 Company Landscape

9.1 Introduction

9.2 Market Share Analysis

9.3 Key Development & Strategies

Chapter 10. Company Profiles

10.1 B. Braun Melsungen AG

10.1.1 Company Overview

10.1.2 Treatment Overview

10.1.3 Financials Overview

10.1.4 Key Developments

10.1.5 SWOT Analysis

10.2 Fresenius Kabi AG

10.2.1 Company Overview

10.2.2 Treatment Overview

10.2.3 Financial Overview

10.2.4 Key Developments

10.2.5 SWOT Analysis

10.3 Baxter International Inc.

10.3.1 Company Overview

10.3.2 Treatment Overview

10.3.3 Financial Overview

10.3.4 Key Development

10.3.5 SWOT Analysis

10.4 Johnson & Johnson Private Limited

10.4.1 Company Overview

10.4.2 Treatment Overview

10.4.3 Financial Overview

10.4.4 Key Development

10.4.5 SWOT Analysis

10.5 Pfizer Inc

10.5.1 Company Overview

10.5.2 Treatment Overview

10.5.3 Financial Overview

10.5.4 Key Developments

10.5.5 SWOT Analysis

10.6 Terumo Corporation

10.6.1 Company Overview

10.6.2 Treatment Overview

10.6.3 Financial Overview

10.6.4 Key Developments

10.6.5 SWOT Analysis

10.7 Smith & Nephew

10.7.1 Company Overview

10.7.2 Treatment Overview

10.7.3 Financial Overview

10.7.4 Key Developments

10.7.5 SWOT Analysis

10.8 Care Fusion Corporation

10.8.1 Company Overview

10.8.2 Treatment Overview

10.8.3 Financials

10.8.4 Key Developments

10.8.5 SWOT Analysis

Chapter 11 MRFR Conclusion

11.1 Key Findings

11.1.1 From CEO’s Viewpoint

11.1.2 Unmet Needs of the Market

11.2 Key Companies to Watch

11.3 Predictions for the Home Infusion Therapy Devices Industry

Chapter 12. Appendix

LIST OF TABLES

Table 1 Global Home Infusion Therapy Devices Market Synopsis, 2020-2027

Table 2 Global Home Infusion Therapy Devices Market Estimates and Forecast, 2020-2027

(USD Million)

Table 3 Global Home Infusion Therapy Devices Market, by Region, 2020-2027 (USD Million)

Table 4 Global Home Infusion Therapy Devices Market, by Product, 2020-2027 (USD Million)

Table 5 Global Home Infusion Therapy Devices Market, by Application, 2020-2027 (USD

Million)

Table 8 North America: Home Infusion Therapy Devices Market, by Product, 2020-2027 (USD

Million)

Table 9 North America: Home Infusion Therapy Devices Market, by Application, 2020-2027

(USD Million)

Table 12 US: Home Infusion Therapy Devices Market, by Product, 2020-2027 (USD Million)

Table 13 US: Home Infusion Therapy Devices Market, by Application, 2020-2027 (USD

Million)

Table 16 Canada: Home Infusion Therapy Devices Market, by Product, 2020-2027 (USD Million)

Table 17 Canada: Home Infusion Therapy Devices Market, by Application, 2020-2027 (USD

Million)

Table 20 Latin America: Home Infusion Therapy Devices Market, by Product, 2020-2027 (USD

Million)

Table 21 Latin America: Home Infusion Therapy Devices Market, by Application, 2020–

2024 (USD Million)

Table 24 Europe: Home Infusion Therapy Devices Market, by Product, 2020-2027 (USD Million)

Table 25 Europe: Home Infusion Therapy Devices Market, by Application, 2020-2027 (USD

Million)

Table 28 Western Europe: Home Infusion Therapy Devices Market, by Product, 2020-2027 (USD

Million)

Table 29 Western Europe: Home Infusion Therapy Devices Market, by Application, 2020–

2024 (USD Million)

Table 32 Eastern Europe: Home Infusion Therapy Devices Market, by Product, 2020-2027 (USD

Million)

Table 33 Eastern Europe: Home Infusion Therapy Devices Market, by Application, 2020-2027 (USD Million)

Table 36 Asia-Pacific: Home Infusion Therapy Devices Market, by Product, 2020-2027 (USD

Million)

Table 37 Asia-Pacific: Home Infusion Therapy Devices Market, by Application, 2020-2027

(USD Million)

Table 40 Middle East & Africa: Home Infusion Therapy Devices Market, by Product, 2020-2027

(USD Million)

Table 41 Middle East & Africa: Home Infusion Therapy Devices Market, by Application,

2020-2027 (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Home Infusion Therapy Devices Market

Figure 3 Segmentation Market Dynamics for Global Home Infusion Therapy Devices Market

Figure 4 Global Home Infusion Therapy Devices Market Share, by Product, 2020

Figure 5 Global Home Infusion Therapy Devices Market Share, by Application, 2020

Figure 7 Global Home Infusion Therapy Devices Market Share, by End User, 2020

Figure 8 Global Home Infusion Therapy Devices Market Share, by Region, 2020

Figure 9 North America: Home Infusion Therapy Devices Market Share, by Country, 2020

Figure 10 Europe: Home Infusion Therapy Devices Market Share, by Country, 2020

Figure 11 Asia-Pacific: Home Infusion Therapy Devices Market Share, by Country, 2020

Figure 12 Middle East & Africa: Home Infusion Therapy Devices Market Share, by Country, 2020

Figure 13 Global Home Infusion Therapy Devices Market: Company Share Analysis, 2020 (%)

Figure 14 Baxter International Inc.: Key Financials

Figure 15 Baxter International Inc.: Segmental Revenue

Figure 16 Baxter International Inc.: Geographical Revenue

Figure 17 B. Braun Melsungen AG.: Key Financials

Figure 18 B. Braun Melsungen AG: Segmental Revenue

Figure 19 B. Braun Melsungen AG: Geographical Revenue

Figure 20 Baxter International Inc.: Key Financials

Figure 21 Baxter International Inc.: Segmental Revenue

Figure 22 Baxter International Inc.: Geographical Revenue

Figure 23 Pfizer Inc.: Key Financials

Figure 24 Pfizer Inc.: Segmental Revenue

Figure 25 Pfizer Inc.: Geographical Revenue



This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.